Panda Surgical selected for prestigious MedTech Innovator 2026 Accelerator cohort
London, UK — May 27, 2026 — Panda Surgical, a University College London-spinout introducing the world’s first dexterous robot for minimally invasive neurosurgery, announced today that it has been selected to join the MedTech Innovator 2026 Accelerator Cohort. Panda Surgical is one of only 65 companies representing the top 4% of over 1,800 global applicants chosen for this year’s program.
MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.
“We are incredibly excited to join this year’s MedTech Innovator cohort,” said Manios Dimitrakakis, Panda Surgical CEO. “This program will help us refine our commercialization strategy, build valuable partnerships, and accelerate our path to market.”
Panda Surgical was selected based on its first-of-its-kind neurosurgical robotic technology, its potential to be a first mover into an expanding neurosurgery market, and its alignment with MTI’s mission to improve patient care through transformative technology.
Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 18-21 in Boston) and/or the MedTech Strategist Innovation Summit (November 3-5 in San Diego), where they will compete for a share of $800,000 in funding.
In addition to joining the accelerator cohort, Panda Surgical has been named to the 2026 MedTech Innovator Index, an exclusive recognition highlighting the most promising medtech startups selected through MTI's rigorous global review process. Inclusion on the Index underscores the Company's position among the top emerging companies shaping the future of healthcare innovation.
The official press-release can be found here.
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing over 20,000+ applicants and fostering the growth of 838 graduates. Alumni have collectively raised $12 billion in follow-on funding, achieved 63 acquisitions, and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow MTI on LinkedIn, and subscribe to its monthly newsletter.
About Panda Surgical
Panda Surgical, a University College London spinout, is developing the world’s first dexterous robot for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support making these complex operations safer, more effective, and more widely adopted.
For further information, please contact: contact@panda-surgical.com
